期刊
ANNUAL REVIEW OF CANCER BIOLOGY, VOL 5, 2021
卷 5, 期 -, 页码 235-257出版社
ANNUAL REVIEWS
DOI: 10.1146/annurev-cancerbio-070820-035832
关键词
cell metabolism; epigenetics; chromatin modification; cancer
类别
资金
- NIH (National Institutes of Health) [R01CA228339, R01CA174761, R01DK116005, K00CA212455, T32GM07229]
This article discusses the bidirectional relationship between epigenetics and metabolism in cancer, including epigenetic control of metabolism and metabolic regulation of chromatin-modifying enzymes. This cross talk plays a crucial role in tumor growth and proliferation, with potential for improving cancer therapy.
Metabolic and epigenetic reprogramming are characteristics of cancer cells that, in many cases, are linked. Oncogenic signaling, diet, and tumor microenvironment each influence the availability of metabolites that are substrates or inhibitors of epigenetic enzymes. Reciprocally, altered expression or activity of chromatin-modifying enzymes can exert direct and indirect effects on cellular metabolism. In this article, we discuss the bidirectional relationship between epigenetics and metabolism in cancer. First, we focus on epigenetic control of metabolism, highlighting evidence that alterations in histone modifications, chromatin remodeling, or the enhancer landscape can drive metabolic features that support growth and proliferation. We then discuss metabolic regulation of chromatin-modifying enzymes and roles in tumor growth and progression. Throughout, we highlight proposed therapeutic and dietary interventions that leverage metabolic-epigenetic cross talk and have the potential to improve cancer therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据